We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Diagnosis of Early Gastric Cancer Aided by Optimal Band Imaging

By Biotechdaily staff writers
Posted on 10 Mar 2008
New research revealed that optimal band imaging used with an endoscope provided images that unmistakably identified depressed-type early gastric cancer without magnification in 96% of study participants. More...


Gastric cancer is one of the most prevalent types of cancer in the world. If gastric cancer is found early, the five-year survival rate increases nearly 90%. In contrast, most patients with advanced gastric cancer have a poor prognosis. Gastric cancer is classified as elevated, flat, and depressed types. In spite of improvements in endoscopic technologies, depressed-type early gastric cancer is challenging to diagnose because it manifests as slight alterations in color and shape. Variations in color, however, can also mean inflammation, so it is difficult to determine what is benign and what is malignant. Therefore, biopsies must then be taken.

"In our comparative study, the optimal band imaging system with endoscopy showed contrasting images that could delineate the depressed-type early gastric cancers more easily than conventional endoscopy,” said the study's lead author Hiroyuki Osawa, M.D., Jichi Medical University (Tochigi-Ken, Japan). "A distinct demarcation was observed endoscopically between the reddish images of the cancerous lesion and the yellowish images of the surrounding noncancerous area. This is the first report of optimal band images for early gastric cancer.”

Optimal band imaging (OBI) was developed with the goal of enhancing the capillary pattern and pit patterns of lesions in endoscopic images. In contrast to narrow band imaging, in which the bandwidth of spectral transmittance is narrowed by optical filters, the OBI system is based on a new spectral estimation technique that replaces the need for optical filters. OBI takes an ordinary endoscopic image from the video processor and arithmetically processes the reflected photons to reconstitute virtual images for a choice of different wavelengths.

An OBI system with electronic endoscope for the upper-gastrointestinal tract was used in this prospective study. Twenty-seven patients between May and December 2006 who were diagnosed with conventional endoscopy as having depressed-type early gastric cancer participated in the study. The mean age of the patients was 65.3 years with 23 men and 4 women. Twenty-four patients were diagnosed with differentiated adenocarcinoma and three patients with undifferentiated adenocarcinoma by the histopathologic evaluation of biopsy specimens. Researchers used the OBI system without magnification to observe the entire stomach because of the ample light intensity.

With the OBI system, depressed type-early gastric cancer in 26 of 27 cases were easily identified because it clearly showed contrasting demarcation lines between the reddish images of the cancerous lesions and the yellowish images of the surrounding noncancerous area. A 40-fold magnification was then applied to observe the pit pattern, the disappearance of pit pattern, or an irregular microvascular pattern of the cancerous lesions, which further enhanced the demarcation of the cancer and the noncancerous areas.

The researchers concluded that OBI images were better than traditional endoscopy images in identifying depressed-type early gastric cancer, but said that additional study is needed. They noted that even medical students, who had not had considerable amounts of clinical endoscopic experience, were able to easily identify the demarcation line between cancer and noncancerous areas in optimal band images versus conventional endoscopic images. OBI is available even without magnification during routine endoscopy because the system provides the same light intensity as conventional endoscopy. The researchers reported that such nonmagnified optimal band images might be ideal for screening, whereas magnified optimal band images are more suitable for detailed examination of early gastric cancer.

Endoscopy is performed by specially trained physicians called endoscopists using the most current technology to diagnose and treat diseases of the gastrointestinal tract. Using flexible, thin tubes called endoscopes, endoscopists are able to access the human digestive tract without incisions via natural orifices. Endoscopes are designed with high-intensity lighting and fitted with precision devices that allow viewing and treatment of the gastrointestinal system. In many cases, screening or treatment of conditions can be delivered via the endoscope without the need for further sedation, treatment or hospital stay.

The study was published in the February 2008 issue of Gastrointestinal Endoscopy.


Related Links:
Jichi Medical University

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.